Clinical trials recruiting for MAPK Pathway Gene Mutation
Fewer than 3 recruiting trials found.
1
Recruiting trials
10
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| NST-628 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| Florida | 1 |
| New York | 1 |
| Pennsylvania | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Utah | 1 |
| Virginia | 1 |
Top cities
Austin, Texas 1Buffalo, New York 1Dallas, Texas 1Denver, Colorado 1Fairfax, Virginia 1Houston, Texas 1Nashville, Tennessee 1New Haven, Connecticut 1New York, New York 1Pittsburgh, Pennsylvania 1
Self-screener
Recruiting trials
- A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Related conditions
Trials recruiting for MAPK Pathway Gene Mutation often also study these conditions. Each links to its own recruiting-trial list.
Solid Tumor, Adult 38Ras (KRAS or NRAS) Gene Mutation 3Oncology 8Non-small cell lung cancer 507Melanoma 487Glioma 9
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for MAPK Pathway Gene Mutation trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.